Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Martin Kotrč"'
Autor:
Martin Kotrc, Jozef Bartunek, Jan Benes, Monika Beles, Marc Vanderheyden, Filip Casselman, Tomas Ondrus, Yujing Mo, Frank Van Praet, Martin Penicka
Publikováno v:
ESC Heart Failure, Vol 9, Iss 4, Pp 2686-2694 (2022)
Abstract Aims Identification of heart failure (HF) patients with secondary mitral regurgitation (SMR) that benefit from mitral valve (MV) repair remains challenging. We have focused on the role of left ventricular global longitudinal strain (LV‐GLS
Externí odkaz:
https://doaj.org/article/db04efd39fed4df2876ca076db03421e
Autor:
Peter Wohlfahrt, MD, PhD, Dominik Jenča, MD, Vojtěch Melenovský, MD, PhD, Jolana Mrázková, Mgr, Marek Šramko, MD, PhD, Martin Kotrč, MD, Michael Želízko, MD, Věra Adámková, MD, PhD, Francisco Lopez-Jimenez, MD, MSc, MBA, Jan Piťha, MD, PhD, Josef Kautzner, MD, PhD
Publikováno v:
Mayo Clinic Proceedings: Digital Health, Vol 2, Iss 3, Pp 352-360 (2024)
Objective: To evaluate the effect of smart device-based telerehabilitation on Vo2peak in patients after myocardial infarction. Patients and Methods: This was a pilot, single-center, randomized, cross-over study with a 3-month intervention. One month
Externí odkaz:
https://doaj.org/article/c54556d7a7594845a4ee28d4bb58a0e9
Autor:
Peter Wohlfahrt, Dominik Jenča, Vojtěch Melenovský, Josef Stehlik, John A. Spertus, Jolana Mrázková, Marek Šramko, Martin Kotrč, Michael Želízko, Věra Adámková, Jan Piťha, Josef Kautzner
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 2 (2024)
Background Heart failure is a common complication after myocardial infarction (MI) and is associated with increased mortality. Whether remote heart failure symptoms assessment after MI can improve risk stratification is unknown. The authors evaluated
Externí odkaz:
https://doaj.org/article/8e6d6cd5fcf94377a1ee6793519a8c0f
Autor:
Peter Wohlfahrt, Dominik Jenča, Vojtěch Melenovský, Petr Jarolím, Dana Dlouhá, Marek Šramko, Martin Kotrč, Michael Želízko, Jolana Mrázková, Jan Piťha, Věra Adámková, Josef Kautzner
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 6 (2023)
Background The hypocretin/orexin system has been shown to play a role in heart failure. Whether it also influences myocardial infarction (MI) outcomes is unknown. We evaluated the effect of the rs7767652 minor allele T associated with decreased trans
Externí odkaz:
https://doaj.org/article/44d740c12e5a41ca9cb54fe108d3ebbf
Autor:
Peter Wohlfahrt, Dominik Jenča, Vojtěch Melenovský, Marek Šramko, Martin Kotrč, Michael Želízko, Jolana Mrázková, Věra Adámková, Jan Pitha, Josef Kautzner
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundLeft ventricular ejection fraction (EF) is an independent predictor of adverse outcomes after myocardial infarction (MI). However, current data on trajectories and determinants of EF are scarce. The present study aimed to describe the epide
Externí odkaz:
https://doaj.org/article/de1df35f829b4df89220837b1c0e227f
Publikováno v:
Intervenční a akutní kardiologie. 22:27-34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4af3f419d7322e08a01a4e1804e7df61
https://doi.org/10.36290/kar.2023.004
https://doi.org/10.36290/kar.2023.004
Autor:
Jan Benes, Katerina Kroupova, Martin Kotrc, Jiri Petrak, Petr Jarolim, Vendula Novosadova, Josef Kautzner, Vojtech Melenovsky
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract There is no biomarker reflecting right ventricular dysfunction in HFrEF patients used in clinical practice. We have aimed to look for a circulating marker of RV dysfunction employing a quantitative proteomic strategy. The Olink Proteomics Mu
Externí odkaz:
https://doaj.org/article/126dcc6c0c7c44c7964fad0be6c919ae
Autor:
Tereza Tykvartova, Matus Miklovic, Martin Kotrc, Petra Skaroupkova, Ludmila Kazdova, Jaroslava Trnovska, Vojtech Skop, Michal Kolar, Jiri Novotny, Vojtech Melenovsky
Publikováno v:
Pharmacology Research & Perspectives, Vol 12, Iss 1, Pp n/a-n/a (2024)
Abstract While phosphodiesterase‐5 inhibition (PED5i) may prevent hypertrophy and failure in pressure‐overloaded heart in an experimental model, the impact of PDE5i on volume‐overload (VO)‐induced hypertrophy is unknown. It is also unclear wh
Externí odkaz:
https://doaj.org/article/d062805e3709438687a940351a7af7a8
Publikováno v:
Intervenční a akutní kardiologie. 15:33-36
Dominantni přicinou kardioembolizaci je tromboza ouska leve sině při fibrilaci sini. U nemocných s proběhlými krvacivými komplikacemi antikoagulacni terapie je možnou alternativou řeseni stavu uzavěr ouska leve sině a ukonceni antikoagulac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::303fb92f6517dd58397a4dd73e5c662b
https://doi.org/10.36290/kar.2016.006
https://doi.org/10.36290/kar.2016.006
Autor:
Jan Benes, Martin Kotrc, Peter Wohlfahrt, Katerina Kroupova, Marek Tupy, Josef Kautzner, Vojtech Melenovsky
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundRight ventricular (RV) function is currently being evaluated solely according to the properties of RV myocardium. We have tested a concept that in patients with heart failure with reduced ejection fraction (HFrEF), RV assessment should inte
Externí odkaz:
https://doaj.org/article/f0c064611d1246ab9f6d86c500aa3b31